A Randomized, Double-Blind, Controlled Evaluation of Tenofovir DF versus Adefovir Dipivoxil for the Treatment of HBeAg Positive Chronic Hepatitis B
Latest Information Update: 05 Oct 2021
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary) ; Adefovir dipivoxil; Emtricitabine/tenofovir disoproxil fumarate
- Indications Hepatitis B
- Focus Registrational; Therapeutic Use
- Sponsors Gilead Sciences
- 29 Aug 2020 Data taken from (GS-US-174-0102, GS-US-174-0103) trials to develope ML models that identify and quantify histologic features in a clinical study of HBV patients receiving antiviral therapy presented at The International Liver Congress 2020
- 29 Aug 2020 Results of a pooled analysis of data pooled from 5 Phase 3 studies evaluating tenofovir based regimens to determine the associations of ALT flares with different treatment outcomes presented at The International Liver Congress 2020
- 09 Jun 2019 Trial has been completed in UK.